1. Market Research
  2. > Drug Discovery And Development Industry

Drug Development Industry, February 2016 Market Reports from Top Publishers

You might be interested in: Pharmaceutical, Therapeutics, Anti-Infective, Biosimilar, Company Sales Figures, Oncology, Ophthalmology, Antidepressant, Disease Management, Neurology, Biomarker, Clinical Trial, Diagnostics, Drug-eluting Stent, Antibody, Drug Delivery, Over-The-Counter Drug, Stem Cell, Veterinary Drug, Diagnostic Test.


 
1-10 of 14 reports for Drug Development

Purchase Reports From Reputable Market Research Publishers

Biosimulation Market by Product, Application  & by End Users - Global Forecast to 2020

Biosimulation Market by Product, Application & by End Users - Global Forecast to 2020

  • $ 4 650
  • Industry report
  • July 2015
  • by MarketsandMarkets

The global biosimulation market is expected to reach USD 2,107.99 million by 2020 from USD 1,034.93 million in 2015, at a CAGR of 15.29% between 2015 and 2020. By product, the market includes software ...

Translational Drug Development - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Translational Drug Development - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • August 2015
  • by Global Data

Summary Translational Drug Development (TD2) (TGen) is a drug development service company that offers oncology treatments to cancer patients. The company offers services including preclinical services, ...

Global Alliance for TB Drug Development - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Global Alliance for TB Drug Development - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2015
  • by Global Data

Summary Global Alliance for TB Drug Development (TB Alliance) is a non-profit organization that discovers and develops drugs to treat tuberculosis. The organization offers products such as natural products, ...

Best Practices: Industry Clouds Driving the Future of Knowledge-Based Drug Development in the Life Sciences

Best Practices: Industry Clouds Driving the Future of Knowledge-Based Drug Development in the Life Sciences

  • $ 4 500
  • Industry report
  • June 2015
  • by IDC

This IDC Health Insights report examines best practices in the use of industry clouds in the life science industry. With the industry's heightened focus on core competencies, several opportunities fo ...

Nanoparticles in Biotechnology, Drug Development and Drug Delivery

Nanoparticles in Biotechnology, Drug Development and Drug Delivery

  • $ 6 650
  • Industry report
  • August 2014
  • by BCC Research

This BCC Research report provides detailed product analyses within health and wellness subsegments to overall industry trends in order to quantify and qualify the market for drug products for treating ...

Physician Views: With drug developers on the brink of Phase III for NASH, how large is the actual market opportunity?

Physician Views: With drug developers on the brink of Phase III for NASH, how large is the actual market opportunity?

  • $ 754
  • Industry report
  • August 2014
  • by Firstword Pharma

While no drugs are approved for non-alcoholic steatohepatitis (NASH), at least eight agents have moved into clinical testing in the setting, including two small molecules on the verge of pivotal trials, ...

Pediatric drug development - Regulatory challenges and commercial opportunities

Pediatric drug development - Regulatory challenges and commercial opportunities

  • $ 2 995
  • Industry report
  • July 2014
  • by GBI Research

Although pediatrics represent around two-fifths of the global population the market for pediatric medicines remains relatively small (accounting for

Adaptive Licensing - A Holistic Approach to Drug Development and Regulation, CBR Pharma Insights

Adaptive Licensing - A Holistic Approach to Drug Development and Regulation, CBR Pharma Insights

  • $ 2 995
  • Industry report
  • July 2014
  • by CBR Pharma Insights

Adaptive Licensing (AL) is a flexible approach to drug development and regulation, with two live pilot schemes accepted by the European Medicines Agency (EMA). The system acknowledges that levels of uncertainty ...

Pediatric drug development - Regulatory challenges and commercial opportunities, CBR Pharma Insights

Pediatric drug development - Regulatory challenges and commercial opportunities, CBR Pharma Insights

  • $ 2 995
  • Industry report
  • July 2014
  • by CBR Pharma Insights

Although pediatrics represent around two-fifths of the global population the market for pediatric medicines remains relatively small (accounting for

Adaptive Licensing - A Holistic Approach to Drug Development and Regulation

Adaptive Licensing - A Holistic Approach to Drug Development and Regulation

  • $ 2 995
  • Industry report
  • July 2014
  • by GBI Research

Adaptive Licensing (AL) is a flexible approach to drug development and regulation, with two live pilot schemes accepted by the European Medicines Agency (EMA). The system acknowledges that levels of uncertainty ...

About 5 400 reports for Drug Development

Download Unlimited Documents from Trusted Public Sources

Covance - Annual Report, 2014

  • January 2014
    128 pages
  • Credit  

  • United States  

View report >

Analyst Report, 2013

January 2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.